# Down Syndrome Obstructive Sleep Apnea

> **NCT06043440** · PHASE2 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 230 (estimated)

## Conditions studied

- Down Syndrome
- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Oxygen

## Key facts

- **NCT ID:** NCT06043440
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-24
- **Primary completion:** 2027-11-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2025-04-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06043440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06043440, "Down Syndrome Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06043440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*